NCT04245371View on ClinicalTrials.gov

Lidocaine Patch 1.8% for Moderate to Severe Pain From Carpal Tunnel Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

February 24, 2020

Primary Completion Date

May 7, 2023

Study Completion Date

May 7, 2023

Conditions
Carpal Tunnel Syndrome
Interventions
DRUG

Lidocaine 1.8%

Topical Patch

DRUG

Placebo

Matching Placebo Patch

Trial Locations (1)

48307

Michigan Orthopaedic & Spine Surgeons, Rochester Hills

All Listed Sponsors
collaborator

Scilex Ltd.

INDUSTRY

lead

John Papakonstantinou, MD

OTHER

NCT04245371 - Lidocaine Patch 1.8% for Moderate to Severe Pain From Carpal Tunnel Syndrome | Biotech Hunter | Biotech Hunter